WHO ICTRP trial
The clinical trial of Thalidomide maintenance therapy for multiple myeloma…
JPRN-UMIN000006182 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000006182 |
|---|---|
| Public title | The clinical trial of Thalidomide maintenance therapy for multiple myeloma patients ineligible for hematopoietic stem cell transplantation. |
| Scientific title | The clinical trial of Thalidomide maintenance therapy for multiple myeloma patients ineligible for hematopoietic stem cell transplantation. - COnsolidation/MaintEnance with Thalidomide: COMET STUDY/J-MEN 01 STUDY |
| Primary sponsor | Japan Myeloma Expert Network (J-MEN) of Japan Myeloma Network (JMN) |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | multiple myeloma |
| Interventions | Thaled capsule 50 administrated daily for 2-yr after induction therapy. Thaled capsule 100 administrated daily for 2-yr after induction therapy. The Participants are followed up for 2-yr after induction therapy. |
| Registration date | Aug 19, 2011 |
| Target size | 60 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: